Cathepsin B-Activated PET Tracer for In Vivo Tumor Imaging
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A novel PET tracer, [⁶⁸Ga]NOTA-SF-CV, effectively detects cathepsin B, a key cancer biomarker. Its unique design enhances tumor retention and imaging signals for improved diagnosis of cathepsin B-related diseases.
Area Of Science
- Biomedical Imaging
- Molecular Imaging
- Radiochemistry
Background
- Cathepsin B is a crucial biomarker overexpressed in many cancers, essential for tumor diagnosis and treatment.
- Stimulus-responsive scaffolds (SF) can detect tumor-associated enzyme activity.
- Developing specific PET tracers is vital for visualizing enzyme expression in vivo.
Purpose Of The Study
- To develop a novel small-molecule PET tracer, [⁶⁸Ga]NOTA-SF-CV, for cathepsin B detection.
- To investigate the tracer's ability to visualize cathepsin B expression in tumors.
- To evaluate the potential of [⁶⁸Ga]NOTA-SF-CV for diagnosing cathepsin B-related diseases.
Main Methods
- Synthesis of the [⁶⁸Ga]NOTA-SF-CV PET tracer by combining an SF scaffold with a cathepsin B substrate (Cit-Val).
- Evaluation of tracer activation by cathepsin B, leading to reduced hydrophilicity and enhanced retention via prevention of exocytosis.
- In vivo microPET imaging in tumor models to assess targeting specificity and signal amplification.
Main Results
- [⁶⁸Ga]NOTA-SF-CV demonstrated specific targeting of cathepsin B.
- The tracer formed a cyclized product upon cathepsin B activation, reducing hydrophilicity and increasing retention in tumor cells.
- MicroPET imaging successfully visualized cathepsin B expression levels in various tumors.
Conclusions
- [⁶⁸Ga]NOTA-SF-CV is a promising PET tracer for cathepsin B detection.
- The tracer's design allows for enhanced retention and signal amplification in tumors overexpressing cathepsin B.
- [⁶⁸Ga]NOTA-SF-CV holds potential for diagnosing cathepsin B-related cancers.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radioactive Tracer: PET involves using biologically active molecules labeled with radioactive isotopes, known as tracers or radiotracers. The...